The Impact of the Reading Habit on the Writing Skills of Primary Students

Rosli et al. (2018) suggested that reading is an attempt to comprehend the writer’s message, while Alnahdi and Aftab (2020) stated that it is a gateway to all other information, which may lead to understanding the world outside the text. Hence, Al-Jarf (2021) and Dadzie (2008) asserted that reading is a multifaceted cognitive process of comprehending words written in a textual form that allows readers to enhance their knowledge for personal growth and academic success. This study investigated the impact of the reading habit of the Grade Three students of a selected English Medium Private school, in Kandy, on their writing skills. Since reading lays the foundation for all the other skills in the English language, it is important to inculcate the reading habit from a young age. The research was carried out with a sample population of 30 students (from 03 classes), selected under the random sampling method. The class teachers of the three classes were also included in the study. The students were given a questionnaire that included 10 questions, under 4 criteria which would assess their level of reading habit. A separate questionnaire was given to the teachers that would assess the writing skill of the students under 04 criteria. Each questionnaire was then given scales to identify the level of reading habits as well as writing skills. The major findings of this study were that the students who have a good level of reading habits, have a good level of writing skills. The students who have a low level of reading habits, have a poor level of writing skills. It can be identified that reading is important to improve the writing skill of students. Inculcating reading habits within the student at a young age would help to create better writers for the future. Therefore, teachers should encourage students to improve their reading habits

Targeting late diagnosis of HIV in Kent, Medway and Picardy: evaluation of interventions in the Anglo-French IMPRESS Health 2 (Interreg IVA Channel Programme) project 4282

This report outlines the results and final stakeholder evaluations for the intervention phase (phase 3) of the Interreg IVA Channel Programme 4282 IMPRESSHealth 2 study. It describes how recommendations from the phase 1 report were implemented in Kent, Medway and Picardy in Northern France, the impact which these had on the uptake and timeliness of HIV testing in these areas; and analysis of the reasons for variance between the two countries (UK and France). The report contains examples of some of the public health and social media materials developed to increase the uptake and timeliness of HIV testing, and the results of the stakeholder assessment of its success. Overall, the impact of the interventions have been successful, with widespread increases in both the number and timeliness of HIV testing in the UK though less so in France. Reasons for these differences are discussed in the report. The report also highlights the huge contribution which social and broadcasting media can make to public health campaigns of this nature, and the value of multi-sector and inter-organisational team working

Outcomes following trauma laparotomy for hypotensive trauma patients: A UK military and civilian perspective.

BACKGROUND: The management of trauma patients has changed radically in the last decade, and studies have shown overall improvements in survival. However, reduction in mortality for the many may obscure a lack of progress in some high-risk patients. We sought to examine the outcomes for hypotensive patients requiring laparotomy in UK military and civilian cohorts. METHODS: We undertook a review of two prospectively maintained trauma databases: the UK Joint Theatre Trauma Registry for the military cohort (February 4, 2003, to September 21, 2014) and the trauma registry of the Royal London Hospital major trauma center (January 1, 2012, to January 1, 2017) for civilian patients. Adults undergoing trauma laparotomy within 90 minutes of arrival at the emergency department (ED) were included. RESULTS: Hypotension was present on arrival at the ED in 155 (20.4%) of 761 military patients. Mortality was higher in hypotensive casualties (25.8% vs. 9.7% in normotensive casualties; p < 0.001). Hypotension was present on arrival at the ED in 63 (35.7%) of 176 civilian patients. Mortality was higher in hypotensive patients (47.6% vs. 12.4% in normotensive patients; p < 0.001). In both cohorts of hypotensive patients, neither the average injury severity, the prehospital time, the ED arrival systolic blood pressure, nor mortality rate changed significantly during the study period. CONCLUSIONS: Despite improvements in survival after trauma for patients overall, the mortality for patients undergoing laparotomy who arrive at the ED with hypotension has not changed and appears stubbornly resistant to all efforts. Specific enquiry and research should continue to be directed at this high-risk group of patients. LEVEL OF EVIDENCE: Prognostic/Epidemiologic, level IV

Elective cancer surgery in COVID-19-free surgical pathways during the SARS-CoV-2 pandemic: An international, multicenter, comparative cohort study

PURPOSE As cancer surgery restarts after the first COVID-19 wave, health care providers urgently require data to determine where elective surgery is best performed. This study aimed to determine whether COVID-19–free surgical pathways were associated with lower postoperative pulmonary complication rates compared with hospitals with no defined pathway. PATIENTS AND METHODS This international, multicenter cohort study included patients who underwent elective surgery for 10 solid cancer types without preoperative suspicion of SARS-CoV-2. Participating hospitals included patients from local emergence of SARS-CoV-2 until April 19, 2020. At the time of surgery, hospitals were defined as having a COVID-19–free surgical pathway (complete segregation of the operating theater, critical care, and inpatient ward areas) or no defined pathway (incomplete or no segregation, areas shared with patients with COVID-19). The primary outcome was 30-day postoperative pulmonary complications (pneumonia, acute respiratory distress syndrome, unexpected ventilation). RESULTS Of 9,171 patients from 447 hospitals in 55 countries, 2,481 were operated on in COVID-19–free surgical pathways. Patients who underwent surgery within COVID-19–free surgical pathways were younger with fewer comorbidities than those in hospitals with no defined pathway but with similar proportions of major surgery. After adjustment, pulmonary complication rates were lower with COVID-19–free surgical pathways (2.2% v 4.9%; adjusted odds ratio [aOR], 0.62; 95% CI, 0.44 to 0.86). This was consistent in sensitivity analyses for low-risk patients (American Society of Anesthesiologists grade 1/2), propensity score–matched models, and patients with negative SARS-CoV-2 preoperative tests. The postoperative SARS-CoV-2 infection rate was also lower in COVID-19–free surgical pathways (2.1% v 3.6%; aOR, 0.53; 95% CI, 0.36 to 0.76). CONCLUSION Within available resources, dedicated COVID-19–free surgical pathways should be established to provide safe elective cancer surgery during current and before future SARS-CoV-2 outbreaks

Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study.

PURPOSE: As cancer surgery restarts after the first COVID-19 wave, health care providers urgently require data to determine where elective surgery is best performed. This study aimed to determine whether COVID-19-free surgical pathways were associated with lower postoperative pulmonary complication rates compared with hospitals with no defined pathway. PATIENTS AND METHODS: This international, multicenter cohort study included patients who underwent elective surgery for 10 solid cancer types without preoperative suspicion of SARS-CoV-2. Participating hospitals included patients from local emergence of SARS-CoV-2 until April 19, 2020. At the time of surgery, hospitals were defined as having a COVID-19-free surgical pathway (complete segregation of the operating theater, critical care, and inpatient ward areas) or no defined pathway (incomplete or no segregation, areas shared with patients with COVID-19). The primary outcome was 30-day postoperative pulmonary complications (pneumonia, acute respiratory distress syndrome, unexpected ventilation). RESULTS: Of 9,171 patients from 447 hospitals in 55 countries, 2,481 were operated on in COVID-19-free surgical pathways. Patients who underwent surgery within COVID-19-free surgical pathways were younger with fewer comorbidities than those in hospitals with no defined pathway but with similar proportions of major surgery. After adjustment, pulmonary complication rates were lower with COVID-19-free surgical pathways (2.2% v 4.9%; adjusted odds ratio [aOR], 0.62; 95% CI, 0.44 to 0.86). This was consistent in sensitivity analyses for low-risk patients (American Society of Anesthesiologists grade 1/2), propensity score-matched models, and patients with negative SARS-CoV-2 preoperative tests. The postoperative SARS-CoV-2 infection rate was also lower in COVID-19-free surgical pathways (2.1% v 3.6%; aOR, 0.53; 95% CI, 0.36 to 0.76). CONCLUSION: Within available resources, dedicated COVID-19-free surgical pathways should be established to provide safe elective cancer surgery during current and before future SARS-CoV-2 outbreaks

Outcomes from elective colorectal cancer surgery during the SARS-CoV-2 pandemic

This study aimed to describe the change in surgical practice and the impact of SARS-CoV-2 on mortality after surgical resection of colorectal cancer during the initial phases of the SARS-CoV-2 pandemic

Inhibition of cell death results in hyperganglionosis: implications for enteric nervous system development

International audienc

Targeting late diagnosis of HIV in Kent, Medway and Picardy: evaluation of interventions in the Anglo-French IMPRESS Health 2 (Interreg IVA Channel Programme) project 4282

This report outlines the results and final stakeholder evaluations for the intervention phase (phase 3) of the Interreg IVA Channel Programme 4282 IMPRESSHealth 2 study. It describes how recommendations from the phase 1 report were implemented in Kent, Medway and Picardy in Northern France, the impact which these had on the uptake and timeliness of HIV testing in these areas; and analysis of the reasons for variance between the two countries (UK and France). The report contains examples of some of the public health and social media materials developed to increase the uptake and timeliness of HIV testing, and the results of the stakeholder assessment of its success. Overall, the impact of the interventions have been successful, with widespread increases in both the number and timeliness of HIV testing in the UK though less so in France. Reasons for these differences are discussed in the report. The report also highlights the huge contribution which social and broadcasting media can make to public health campaigns of this nature, and the value of multi-sector and inter-organisational team working

Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy

Objective: To assess the risks and benefits of administering highly active antiretroviral therapy (HAART) during the treatment of tuberculosis (TB) in HIV-infected patients. Design and methods: HIV-1 patients presenting to 12 HIV centres in Greater London and south-east England with culture-proven TB were identified from January 1996 to June 1999. Case-notes were reviewed retrospectively. Results: Patients (n = 188) were severely immunocompromised with a median CD4 cell count at TB diagnosis of 90 × 106 cells/l (IQR: 30–180). At presentation, 85% (n = 159) were not taking antiretrovirals. A total of 45% commenced HAART during TB treatment, which was associated with significant reductions in viral load, AIDS-defining illness (ADI) [3.5 versus 24.5%; relative risk (RR) = 0.14] and mortality. Only nine of 91 (10%) patients with a CD4 count > 100 × 106 cells/l at TB diagnosis experienced a further ADI, whereas 18 of 92 (20%) patients with a CD4 count < 100 × 106 cells/l developed this complication. Adverse events (AE) occurred in 99 (54%) of 183 patients, one-third of whom changed or interrupted HIV and/or TB medication. The majority of AE occurred within the first 2 months, with peripheral neuropathy (21%), rash (17%) and gastrointestinal upset (10%) occurring most commonly. Conclusions: Many physicians delay HAART in patients presenting with TB because of pill burden, drug/drug interactions and toxicity. Although the use of HAART led to significant reductions in viral load, ADI and mortality, co-infected patients commonly experienced AE leading to interruptions in TB/HIV therapy. We therefore recommend starting HAART early for patients with advanced HIV disease (CD4 100 × 106 cells/l)